ROLMIZAC D CAP

About

Rolmizac D Capsule is a dual-action medication specifically formulated to address conditions related to excessive stomach acid and impaired gastrointestinal motility, such as gastroesophageal reflux disease (GERD) and peptic ulcers. It combines a proton pump inhibitor (PPI), typically rabeprazole or omeprazole, which works by profoundly reducing the production of stomach acid by blocking the proton pumps in the stomach lining. Complementing this, it includes a prokinetic agent like domperidone, which enhances the movement of food through the stomach and intestines, thereby reducing the backward flow of acid into the esophagus and alleviating symptoms like nausea and vomiting. This synergistic approach provides comprehensive relief from heartburn, acid regurgitation, and indigestion, promoting healing of the esophageal and gastric mucosa and improving overall digestive comfort.

Uses

• Treatment of gastroesophageal reflux disease (GERD).
• Management of peptic ulcers and erosive esophagitis.
• Relief from symptoms like heartburn, acid regurgitation, and nausea.
• Treatment of dyspepsia associated with delayed gastric emptying.

Directions For Use

Take one capsule once daily, preferably before a meal, or as directed by your doctor. Do not chew or crush.

Benefits

• Effectively reduces stomach acid production.
• Accelerates gastric emptying and improves gut motility.
• Provides significant relief from heartburn and acid reflux.
• Helps heal esophageal damage and peptic ulcers.
• Reduces nausea and vomiting associated with digestive issues.
• Offers sustained symptom control for GERD.

Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Flatulence
• Dizziness
• Dry mouth
• Constipation
• Skin rash
• Fatigue
• Insomnia
• Increased risk of bone fractures (long-term use)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase stomach acid production and worsen GERD symptoms, counteracting the medication's effect.
• Pregnancy - Consult a doctor before use. PPIs are generally considered category B/C, and domperidone's use in pregnancy requires careful consideration of benefits vs. risks.
• Breastfeeding - Consult a doctor before use. Domperidone can pass into breast milk, and while PPIs are generally considered low risk, medical advice is essential.
• Liver - Use with caution in patients with severe liver impairment; dose adjustment may be necessary.
• Kidney - Use with caution in patients with severe kidney impairment; dose adjustment may be necessary.
• Lung - No specific contraindications, but long-term PPI use has been linked to an increased risk of respiratory infections in some studies.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.